Figure 1From: Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis MMN and subsequent P3a activity across frontocentral scalp regions of the controls (blue) and the at risk (red) groups and reversed MMN/P3a polarity at the left and right temporal sites. Back to article page